跳至主要内容
临床试验/NCT07070895
NCT07070895招募中不适用

A Prospective Decentralized Investigation of the Effect of a Cough Management Feature Inside a Wellness Application (CoughPro) in Refractory or Unexplained Chronic Cough (RCC/UCC)

Hyfe Inc2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2025年3月27日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
Hyfe Inc
入组人数
20
试验地点
2
主要终点
Change in objective cough rate (coughs/hour)

研究概览

简要总结

The goal of this single-cohort clinical trial is to learn whether a smartphone-based Cough Management (CM) program can reduce cough frequency and burden in adults (21-80 years) who have refractory or unexplained chronic cough. 

The main questions it aims to answer are:

  • Does four weeks of using the CM feature in the CoughPro app lower objective cough rate (coughs per hour) compared with each participant's one-week baseline? 
  • Does the program also lessen cough intensity (bout metrics) and improve patient-reported quality-of-life scores on the Leicester Cough Questionnaire and PGI-S?

Participants will:

  • Wear a Hyfe CoughMonitor smartwatch continuously for 6 weeks (1-week baseline, 4-week intervention, 1-week follow-up), charging it nightly. 
  • Complete science-based in-app CM lessons based on behavioral cough-suppression therapy and practice the techniques during the 4-week intervention.
  • Fill out online questionnaires (LCQ and PGI-S) at baseline and at the end of Week 4.
  • Join a brief exit interview, then return the smartwatch and receive a compensation voucher.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 21 or older.
  • Currently suffering from a cough that started at least 8 weeks ago that is largely unproductive (i.e., at least 50% of the time the cough produces zero mucus that needs to be spit out or swallowed).
  • Normal chest X-ray or chest CT scan at some point that was prescribed specifically for their cough.
  • At least one physician visit for cough with standard-of-care therapy but inadequate symptom relief.
  • Stability of treatment: willing to avoid new cough treatments during study or report changes if they occur.
  • Ability to comply: willing/able to wear the watch daily for the required duration of study and to complete all required questionnaires.
  • Informed consent: understanding of the study procedures and agreement to comply with protocol.

排除标准

  • Recent upper respiratory infection (past 4 weeks).
  • History of hemoptysis (coughing up blood) since onset of the current cough.
  • Current smoker (incl. vaping) of any substance.
  • ≥10 consecutive pack-years smoking history within <10 years prior to screening.
  • Diagnosed with a chronic lung condition (COPD, emphysema, lung cancer, IPF, chronic bronchitis, asthma). Note: Suspected asthma without confirmed diagnosis or benefit from asthma therapy is not an exclusion.
  • Current or past head/neck cancer.
  • Difficulty swallowing.
  • On ACE inhibitors, such as Benzapril (Lotensin), Captopril (Capoten), Enalapril/Enalaprilat (Vasotec oral and injectable), Fosinopril (Monopril), Lisinopril (Zestril and Prinivil), Moexipril (Univasc), Perindopril (Aceon), Quinapril (Accupril), Ramipril (Altace), and Trandolapril (Mavik)
  • Prior treatment for cough by a speech-language pathologist.
  • Living with another individual with a frequent cough that would interfere with monitoring.
  • Participation in any cough intervention study within 30 days or 5 half-lives of the intervention.
  • Major scheduled surgery during the study period.

结局指标

主要结局

Change in objective cough rate (coughs/hour)

时间窗: From baseline (week minus 1) to end of Week 4

Change in objective cough rate (coughs/hours) from baseline (week minus 1) to end of Week 4, measured by the CoughMonitor smartwatch.

次要结局

  • Change in cough intensity from baseline to end of Week 4(Fom baseline (week minus 1) to end of week 4)
  • Change in subjective impression of cough burden(From baseline to 4 weeks after starting the intervention.)

研究者

发起方
Hyfe Inc
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验